Globus Medical
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +54.0% | +40.9% | -7.2% | +13.9% | -5.3% | +15.6% | +39.0% | -35.4% | +36.4% | +113.8% | +44.7% | |
| – | +10.7% | +61.0% | +8.5% | -1.0% | +26.7% | +19.2% | +11.1% | -2.3% | +112.1% | +75.5% | +9.0% | |
| – | +35.6% | +18.1% | +29.0% | +49.1% | +19.1% | +3.8% | +13.0% | +7.3% | +60.7% | +2.7% | -8.1% | |
| – | +153.0% | +6.1% | +51.3% | -21.9% | +18.1% | +90.4% | +0.8% | -68.6% | – | – | – | |
| – | – | – | -975.8% | – | – | – | – | – | – | – | – | |
| – | +105.1% | -19.4% | +25.4% | +16.4% | +18.5% | -10.0% | -10.6% | +30.1% | +5.7% | +47.5% | +42.7% | |
| – | +50.6% | -33.9% | +11.8% | +73.5% | -27.3% | -16.4% | +220.4% | -70.6% | – | -158.1% | +101.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -43.8% | +7.2% | +99.8% | +235.0% | -21.0% | -437.3% | – | -327.6% | +56.1% | -62.0% | +250.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -51.1% | -67.7% | -20.3% | +1,903.1% | -25.0% | -258.2% | – | -303.1% | +110.8% | -88.1% | +2,352.2% | |
| – | – | – | -28.5% | -59.6% | +167.4% | -22.0% | -206.1% | – | – | +0.1% | -181.4% | |
| – | +30.8% | +84.0% | -17.4% | +12.7% | -17.0% | +33.5% | +62.3% | -52.4% | +58.2% | +145.2% | +45.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.